Skip to main content
Top
Published in: Respiratory Research 1/2010

Open Access 01-12-2010 | Research

Adaptive immunity to rhinoviruses: sex and age matter

Authors: Melanie L Carroll, Stephanie T Yerkovich, Antonia L Pritchard, Janet M Davies, John W Upham

Published in: Respiratory Research | Issue 1/2010

Login to get access

Abstract

Background

Rhinoviruses (RV) are key triggers in acute asthma exacerbations. Previous studies suggest that men suffer from infectious diseases more frequently and with greater severity than women. Additionally, the immune response to most infections and vaccinations decreases with age. Most immune function studies do not account for such differences, therefore the aim of this study was to determine if the immune response to rhinovirus varies with sex or age.

Methods

Blood mononuclear cells were isolated from 63 healthy individuals and grouped by sex and age (≤50 years old and ≥52 years old). Cells were cultured with rhinovirus 16 at a multiplicity of infection of 1. The chemokine IP-10 was measured at 24 h as an index of innate immunity while IFNγ and IL-13 were measured at 5 days as an index of adaptive immunity.

Results

Rhinovirus induced IFNγ and IL-13 was significantly higher in ≤50 year old women than in age matched men (p < 0.02 and p < 0.05) and ≥52 year old women (p < 0.02 and p > 0.005). There was no sex or age based difference in rhinovirus induced IP-10 expression. Both IFNγ and IL-13 were negatively correlated with age in women but not in men.

Conclusions

This study suggests that pre-menopausal women have a stronger adaptive immune response to rhinovirus infection than men and older people, though the mechanisms responsible for these differences remain to be determined. Our findings highlight the importance of gender and age balance in clinical studies and in the development of new treatments and vaccines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Grissell TV, Powell H, Shafren DR, Boyle MJ, Hensley MJ, Jones PD, Whitehead BF, Gibson PG: Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005, 172 (4): 433-439. 10.1164/rccm.200412-1621OC.PubMedCrossRef Grissell TV, Powell H, Shafren DR, Boyle MJ, Hensley MJ, Jones PD, Whitehead BF, Gibson PG: Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005, 172 (4): 433-439. 10.1164/rccm.200412-1621OC.PubMedCrossRef
2.
go back to reference Khetsuriani N, Kazerouni NN, Erdman DD, Lu X, Redd SC, Anderson LJ, Teague WG: Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007, 119 (2): 314-321. 10.1016/j.jaci.2006.08.041.PubMedCrossRef Khetsuriani N, Kazerouni NN, Erdman DD, Lu X, Redd SC, Anderson LJ, Teague WG: Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007, 119 (2): 314-321. 10.1016/j.jaci.2006.08.041.PubMedCrossRef
3.
4.
go back to reference Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG: Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med. 2003, 115 (4): 272-277. 10.1016/S0002-9343(03)00353-X.PubMedCrossRef Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG: Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med. 2003, 115 (4): 272-277. 10.1016/S0002-9343(03)00353-X.PubMedCrossRef
5.
go back to reference Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL, et al: Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006, 12 (9): 1023-1026. 10.1038/nm1462.PubMedCrossRef Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL, et al: Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006, 12 (9): 1023-1026. 10.1038/nm1462.PubMedCrossRef
6.
go back to reference Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005, 201 (6): 937-947. 10.1084/jem.20041901.PubMedPubMedCentralCrossRef Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE: Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005, 201 (6): 937-947. 10.1084/jem.20041901.PubMedPubMedCentralCrossRef
7.
go back to reference Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE: Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2010, 3 (1): 69-80. 10.1038/mi.2009.109.PubMedPubMedCentralCrossRef Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE: Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2010, 3 (1): 69-80. 10.1038/mi.2009.109.PubMedPubMedCentralCrossRef
8.
go back to reference Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, Finkbeiner WE, Dolganov GM, Widdicombe JH, Boushey HA, et al: In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol. 2009, 123 (6): 1384-1390. 10.1016/j.jaci.2009.03.010. e1382PubMedPubMedCentralCrossRef Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, Finkbeiner WE, Dolganov GM, Widdicombe JH, Boushey HA, et al: In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol. 2009, 123 (6): 1384-1390. 10.1016/j.jaci.2009.03.010. e1382PubMedPubMedCentralCrossRef
9.
go back to reference Bufe A, Gehlhar K, Grage-Griebenow E, Ernst M: Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol. 2002, 127 (1): 82-88. 10.1159/000048173.PubMedCrossRef Bufe A, Gehlhar K, Grage-Griebenow E, Ernst M: Atopic phenotype in children is associated with decreased virus-induced interferon-alpha release. Int Arch Allergy Immunol. 2002, 127 (1): 82-88. 10.1159/000048173.PubMedCrossRef
10.
go back to reference Gehlhar K, Bilitewski C, Reinitz-Rademacher K, Rohde G, Bufe A: Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy. 2006, 36 (3): 331-337. 10.1111/j.1365-2222.2006.02450.x.PubMedCrossRef Gehlhar K, Bilitewski C, Reinitz-Rademacher K, Rohde G, Bufe A: Impaired virus-induced interferon-alpha2 release in adult asthmatic patients. Clin Exp Allergy. 2006, 36 (3): 331-337. 10.1111/j.1365-2222.2006.02450.x.PubMedCrossRef
11.
go back to reference Roponen M, Yerkovich ST, Hollams E, Sly PD, Holt PG, Upham JW: Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J. 2010, 35 (1): 64-71. 10.1183/09031936.00172008.PubMedCrossRef Roponen M, Yerkovich ST, Hollams E, Sly PD, Holt PG, Upham JW: Toll-like receptor 7 function is reduced in adolescents with asthma. Eur Respir J. 2010, 35 (1): 64-71. 10.1183/09031936.00172008.PubMedCrossRef
12.
go back to reference Alper CM, Doyle WJ, Skoner DP, Buchman CA, Cohen S, Gwaltney JM: Prechallenge antibodies moderate disease expression in adults experimentally exposed to rhinovirus strain hanks. Clin Infect Dis. 1998, 27 (1): 119-128. 10.1086/514634.PubMedCrossRef Alper CM, Doyle WJ, Skoner DP, Buchman CA, Cohen S, Gwaltney JM: Prechallenge antibodies moderate disease expression in adults experimentally exposed to rhinovirus strain hanks. Clin Infect Dis. 1998, 27 (1): 119-128. 10.1086/514634.PubMedCrossRef
13.
go back to reference Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE: Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000, 105 (4): 692-698. 10.1067/mai.2000.104785.PubMedCrossRef Parry DE, Busse WW, Sukow KA, Dick CR, Swenson C, Gern JE: Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000, 105 (4): 692-698. 10.1067/mai.2000.104785.PubMedCrossRef
14.
go back to reference Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, Contoli M, Sanderson G, Kon OM, Papi A, et al: Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA. 2008, 105 (36): 13562-13567. 10.1073/pnas.0804181105.PubMedPubMedCentralCrossRef Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T, Contoli M, Sanderson G, Kon OM, Papi A, et al: Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA. 2008, 105 (36): 13562-13567. 10.1073/pnas.0804181105.PubMedPubMedCentralCrossRef
15.
go back to reference Brooks GD, Buchta KA, Swenson CA, Gern JE, Busse WW: Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med. 2003, 168 (9): 1091-1094. 10.1164/rccm.200306-737OC.PubMedCrossRef Brooks GD, Buchta KA, Swenson CA, Gern JE, Busse WW: Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med. 2003, 168 (9): 1091-1094. 10.1164/rccm.200306-737OC.PubMedCrossRef
16.
go back to reference Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL: A defective type 1 response to rhinovirus in atopic asthma. Thorax. 2002, 57 (4): 328-332. 10.1136/thorax.57.4.328.PubMedPubMedCentralCrossRef Papadopoulos NG, Stanciu LA, Papi A, Holgate ST, Johnston SL: A defective type 1 response to rhinovirus in atopic asthma. Thorax. 2002, 57 (4): 328-332. 10.1136/thorax.57.4.328.PubMedPubMedCentralCrossRef
17.
go back to reference Klein SL, Jedlicka A, Pekosz A: The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010, 10 (5): 338-349. 10.1016/S1473-3099(10)70049-9.PubMedCrossRef Klein SL, Jedlicka A, Pekosz A: The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010, 10 (5): 338-349. 10.1016/S1473-3099(10)70049-9.PubMedCrossRef
18.
go back to reference Fish EN: The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008, 8 (9): 737-744. 10.1038/nri2394.PubMedCrossRef Fish EN: The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. 2008, 8 (9): 737-744. 10.1038/nri2394.PubMedCrossRef
19.
go back to reference Loza MJ, Foster S, Bleecker ER, Peters SP, Penn RB: Asthma and gender impact accumulation of T cell subtypes. Respir Res. 2010, 11: 103-10.1186/1465-9921-11-103.PubMedPubMedCentralCrossRef Loza MJ, Foster S, Bleecker ER, Peters SP, Penn RB: Asthma and gender impact accumulation of T cell subtypes. Respir Res. 2010, 11: 103-10.1186/1465-9921-11-103.PubMedPubMedCentralCrossRef
20.
go back to reference Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H: TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006, 177 (4): 2088-2096.PubMedCrossRef Berghofer B, Frommer T, Haley G, Fink L, Bein G, Hackstein H: TLR7 ligands induce higher IFN-alpha production in females. J Immunol. 2006, 177 (4): 2088-2096.PubMedCrossRef
21.
go back to reference Linton PJ, Dorshkind K: Age-related changes in lymphocyte development and function. Nat Immunol. 2004, 5 (2): 133-139. 10.1038/ni1033.PubMedCrossRef Linton PJ, Dorshkind K: Age-related changes in lymphocyte development and function. Nat Immunol. 2004, 5 (2): 133-139. 10.1038/ni1033.PubMedCrossRef
22.
go back to reference Do KA, Treloar SA, Pandeya N, Purdie D, Green AC, Heath AC, Martin NG: Predictive factors of age at menopause in a large Australian twin study. Hum Biol. 1998, 70 (6): 1073-1091.PubMed Do KA, Treloar SA, Pandeya N, Purdie D, Green AC, Heath AC, Martin NG: Predictive factors of age at menopause in a large Australian twin study. Hum Biol. 1998, 70 (6): 1073-1091.PubMed
23.
go back to reference Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D: Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol. 1998, 72 (2): 934-942.PubMedPubMedCentral Sanders SP, Siekierski ES, Porter JD, Richards SM, Proud D: Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol. 1998, 72 (2): 934-942.PubMedPubMedCentral
24.
go back to reference Subauste MC, Jacoby DB, Richards SM, Proud D: Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest. 1995, 96 (1): 549-557. 10.1172/JCI118067.PubMedPubMedCentralCrossRef Subauste MC, Jacoby DB, Richards SM, Proud D: Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest. 1995, 96 (1): 549-557. 10.1172/JCI118067.PubMedPubMedCentralCrossRef
25.
go back to reference Larionov A, Krause A, Miller W: A standard curve based method for relative real time PCR data processing. BMC Bioinformatics. 2005, 6: 62-10.1186/1471-2105-6-62.PubMedPubMedCentralCrossRef Larionov A, Krause A, Miller W: A standard curve based method for relative real time PCR data processing. BMC Bioinformatics. 2005, 6: 62-10.1186/1471-2105-6-62.PubMedPubMedCentralCrossRef
26.
go back to reference Hamalainen HK, Tubman JC, Vikman S, Kyrola T, Ylikoski E, Warrington JA, Lahesmaa R: Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem. 2001, 299 (1): 63-70. 10.1006/abio.2001.5369.PubMedCrossRef Hamalainen HK, Tubman JC, Vikman S, Kyrola T, Ylikoski E, Warrington JA, Lahesmaa R: Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem. 2001, 299 (1): 63-70. 10.1006/abio.2001.5369.PubMedCrossRef
27.
go back to reference Silver N, Best S, Jiang J, Thein SL: Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol. 2006, 7: 33-10.1186/1471-2199-7-33.PubMedPubMedCentralCrossRef Silver N, Best S, Jiang J, Thein SL: Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol. 2006, 7: 33-10.1186/1471-2199-7-33.PubMedPubMedCentralCrossRef
28.
go back to reference Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL: Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002, 359 (9309): 831-834. 10.1016/S0140-6736(02)07953-9.PubMedCrossRef Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL: Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002, 359 (9309): 831-834. 10.1016/S0140-6736(02)07953-9.PubMedCrossRef
Metadata
Title
Adaptive immunity to rhinoviruses: sex and age matter
Authors
Melanie L Carroll
Stephanie T Yerkovich
Antonia L Pritchard
Janet M Davies
John W Upham
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2010
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-11-184

Other articles of this Issue 1/2010

Respiratory Research 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine